146 related articles for article (PubMed ID: 1328135)
1. Pharmacokinetics and biliary elimination of temafloxacin in pigs.
Jehl F; Bresler L; Koechlin C; Merle-Melet M; Didelot JP; Hazebroucq J
J Antimicrob Chemother; 1992 Aug; 30(2):189-96. PubMed ID: 1328135
[TBL] [Abstract][Full Text] [Related]
2. Hepatobiliary elimination of temafloxacin.
Sörgel F; Granneman GR; Mahr G; Kujath P; Fabian W; Nickel P
Clin Pharmacokinet; 1992; 22 Suppl 1():33-42. PubMed ID: 1319869
[TBL] [Abstract][Full Text] [Related]
3. Biliary elimination and hepatic disposition of a new fluoroquinolone, temafloxacin: experimental evaluation.
Brogard JM; Koechlin C; Westphal JF; Blicklé JF; Dorner M; Jehl F
Drugs Exp Clin Res; 1990; 16(8):407-16. PubMed ID: 2097145
[TBL] [Abstract][Full Text] [Related]
4. Penetration of temafloxacin into body tissues and fluids.
Sörgel F
Clin Pharmacokinet; 1992; 22 Suppl 1():57-63. PubMed ID: 1319872
[TBL] [Abstract][Full Text] [Related]
5. [Experimental study on the hepatobiliary kinetics and excretion of temafloxacin. Evidence for production of active metabolites by the rabbit liver].
Brogard JM; Westphal JF; Koechlin C; Jehl F; Dorner M; Blickle JF; Monteil H
Pathol Biol (Paris); 1991 May; 39(5):524-9. PubMed ID: 1881688
[TBL] [Abstract][Full Text] [Related]
6. A review of the pharmacokinetic profile of temafloxacin.
Dudley MN
J Antimicrob Chemother; 1991 Dec; 28 Suppl C():55-64. PubMed ID: 1664830
[TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review.
Sorgel F; Naber KG; Kinzig M; Mahr G; Muth P
Am J Med; 1991 Dec; 91(6A):51S-66S. PubMed ID: 1662896
[TBL] [Abstract][Full Text] [Related]
8. The effect of food on the bioavailability of temafloxacin. A review of 3 studies.
Granneman GR; Mukherjee D
Clin Pharmacokinet; 1992; 22 Suppl 1():48-56. PubMed ID: 1319871
[TBL] [Abstract][Full Text] [Related]
9. Effect of antacid medication on the pharmacokinetics of temafloxacin.
Granneman GR; Stephan U; Birner B; Sörgel F; Mukherjee D
Clin Pharmacokinet; 1992; 22 Suppl 1():83-9. PubMed ID: 1319875
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of temafloxacin in patients with liver impairment.
Granneman GR; Mahr G; Locke C; Nickel P; Kirch W; Fabian W; Kinzig M; Naber KG; Sörgel F
Clin Pharmacokinet; 1992; 22 Suppl 1():24-32. PubMed ID: 1319868
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of temafloxacin after multiple oral administration.
Granneman GR
Clin Pharmacokinet; 1992; 22 Suppl 1():14-23. PubMed ID: 1319867
[TBL] [Abstract][Full Text] [Related]
12. Effect of cimetidine on the pharmacokinetics of temafloxacin.
Sörgel F; Granneman GR; Stephan U; Locke C
Clin Pharmacokinet; 1992; 22 Suppl 1():75-82. PubMed ID: 1319874
[TBL] [Abstract][Full Text] [Related]
13. The relative bioavailability of temafloxacin administered through a nasogastric tube with and without enteral feeding.
Lubowski TJ; Nightingale CH; Sweeney K; Quintiliani R
Clin Pharmacokinet; 1992; 22 Suppl 1():43-7. PubMed ID: 1319870
[TBL] [Abstract][Full Text] [Related]
14. The influence of age on the pharmacokinetics of temafloxacin.
Granneman GR; Guay DR
Am J Med; 1991 Dec; 91(6A):71S-75S. PubMed ID: 1662898
[TBL] [Abstract][Full Text] [Related]
15. Kinetic disposition of temafloxacin and ciprofloxacin in a murine model of pneumococcal pneumonia. Relevance for drug efficacy.
Vallée E; Azoulay-Dupuis E; Bauchet J; Pocidalo JJ
J Pharmacol Exp Ther; 1992 Sep; 262(3):1203-8. PubMed ID: 1326627
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of temafloxacin in humans after single oral doses.
Granneman GR; Carpentier P; Morrison PJ; Pernet AG
Antimicrob Agents Chemother; 1991 Mar; 35(3):436-41. PubMed ID: 2039194
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of temafloxacin in humans after multiple oral doses.
Granneman GR; Carpentier P; Morrison PJ; Pernet AG
Antimicrob Agents Chemother; 1992 Feb; 36(2):378-86. PubMed ID: 1318680
[TBL] [Abstract][Full Text] [Related]
18. The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin.
Nye K; Shi YG; Andrews JM; Ashby JP; Wise R
J Antimicrob Chemother; 1989 Sep; 24(3):415-24. PubMed ID: 2808194
[TBL] [Abstract][Full Text] [Related]
19. Biliary excretion of rufloxacin in humans.
Privitera G; Nicastro G; Imbimbo BP; Cesana M; Visconti M; Lombardi F; Tagliabue G; Faleschini E; Colturani F; Franzini P
Antimicrob Agents Chemother; 1993 Dec; 37(12):2545-9. PubMed ID: 8109915
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and metabolism of single oral doses of trovafloxacin.
Vincent J; Teng R; Dalvie DK; Friedman HL
Am J Surg; 1998 Dec; 176(6A Suppl):8S-13S. PubMed ID: 9935250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
